REVOLAX Deep Lidocaine Dermal Filler
Medical-grade hyaluronic acid filler with 24mg/ml concentration and 0.3% lidocaine, engineered for deep tissue augmentation. Features monophasic cross-linking technology with 8-18 month longevity (clinical study data). FDA-equivalent manufactured product with <0.0015 UI/mg endotoxin level. Ideal for NLF correction (Nasolabial Fold Severity Scale Grade 2-4).
▲ Core Advantages
▸ High-density HA matrix (1.2MPa viscosity)
▸ Low swelling profile (23% vs. competitor avg.)
▸ Precision 27G needle delivery
▸ CE-marked manufacturing
▸ Immediate volume restoration
▸ 98.7% patient comfort rate*
▸ <1% complication incidence
▸ Phosphate buffer stabilized
▲ Cross-Linking Innovation
• BDDE cross-linked at 6-8% optimal ratio
• Particle size: 350-500μm (ultrasound data)
• G-prime: 450 Pa (rheometer measurement)
• Cohesivity Grade: 4 (Hyaluronic Acid Quality Scale)
▲ Clinical Specifications
Packaging: 1.1ml glass syringe ×1
Needle: Sterile 27G (0.4mm ×13mm)
Storage: 2-25°C protected from light
Shelf Life: 36 months from manufacture
▲ Injection Protocol
1. Aseptic technique mandatory
2. Depth: Subdermal layer (2.5-4.0mm)
3. Retrograde linear threading preferred
4. Max 0.2ml per injection pass
5. Post-massage protocol required
*For licensed practitioners only. Not for vascular danger zones. Results may vary based on injection technique and patient metabolism. Contraindications include autoimmune disorders and anticoagulant therapy. Hyaluronidase emergency protocol must be accessible.
Reviews
There are no reviews yet.